πŸ‡ΊπŸ‡Έ FDA
Patent

US 6211195

CRF antagonistic thiophenopyridines

expired A61PA61P25/22A61P25/24

Quick answer

US patent 6211195 (CRF antagonistic thiophenopyridines) held by Neurocrine Biosciences, Inc. expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P25/22, A61P25/24, A61P25/30, A61P43/00